Titan Medical (NASDAQ:TMDI)
Gráfico Histórico do Ativo
De Jun 2018 até Jun 2020
Titan Medical Inc. (“Titan” or the “Company”) (TSX:
TMD) (Nasdaq: TMDI), a medical device company focused on the
design, development and commercialization of a robotic surgical system
for application in single-port minimally invasive surgery, reported
shareholder vote results from the Company’s Annual and Special Meeting
held on Wednesday, May 29, 2019.
All of management’s nominees for election were duly elected as directors
of the Company by the shareholders present or represented by proxy at
the meeting. A total of 22,305,951 of the 31,150,237 common shares
outstanding were voted at the meeting. The results of the vote were
reported to the meeting by Computershare, which acted as scrutineer at
the meeting, as follows:
The appointment of BDO Canada LLP as Auditors of the Company was
approved by shareholders (with 21,482,357 votes for and 823,594 votes
withheld) in respect of the motion.
Shareholders passed the motion (with 3,637,601 votes for and 2,111,508
votes against) authorizing the SU Plan and DSU Plan.
Shareholders passed the motion (with 3,439,022 votes for and 2,310,087
votes against) authorizing amendments to the Stock Option Plan.
Shareholders passed the motion (with 3,529,202 votes for and 2,252,734
votes against) authorizing the reduction of the exercise prices of
certain options granted to executive officers and employees under the
Further particulars of the resolutions referenced above are set forth in
the management information circular of the Company dated April 29, 2019.
The Company intends to post a video replay of the Annual and Special
Meeting on the investor tab of its website, www.titanmedicalinc.com,
before June 30, 2019.
About Titan Medical Inc.
Titan Medical Inc. is focused on computer-assisted robotic surgical
technologies for application in MIS. The Company is developing the SPORT
Surgical System, a single-port robotic surgical system comprised of a
surgeon-controlled patient cart that includes a 3D high-definition
vision system and multi-articulating instruments for performing MIS
procedures, and a surgeon workstation that provides an advanced
ergonomic interface to the patient cart and a 3D endoscopic view inside
the patient’s body. Titan intends initially to pursue focused surgical
indications for the SPORT Surgical System, which may include one or more
of gynecologic, urologic, colorectal or general abdominal procedures.
For more information, please visit the Company’s website at www.titanmedicalinc.com.
This news release contains “forward-looking statements” which reflect
the current expectations of management of the Company’s future growth,
results of operations, performance and business prospects and
opportunities. Wherever possible, words such as “may”, “would”, “could”,
“will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”,
“potential for” and similar expressions have been used to identify these
forward-looking statements. These statements reflect management’s
current beliefs with respect to future events and are based on
information currently available to management. Forward-looking
statements involve significant risks, uncertainties and assumptions.
Many factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by such
forward-looking statements, including, without limitation, those listed
in the “Risk Factors” section of the Company’s Annual Information Form
dated March 29, 2019 (which may be viewed at www.sedar.com).
Should one or more of these risks or uncertainties materialize, or
should assumptions underlying the forward-looking statements prove
incorrect, actual results, performance, or achievements may vary
materially from those expressed or implied by the forward-looking
statements contained in this news release. These factors should be
considered carefully, and prospective investors should not place undue
reliance on the forward-looking statements. Although the forward-looking
statements contained in the news release are based upon what management
currently believes to be reasonable assumptions, the Company cannot
assure prospective investors that actual results, performance or
achievements will be consistent with these forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190531005332/en/
LHA Investor RelationsKim Sutton Golodetz(212) email@example.comBruce